Answers are grounded in this paper and cite their sources.
This study examines a single subject (LS) experiencing severe episodic colonic inflammation and associated gut microbiome dysbiosis. Metagenomic sequencing of LS's stool samples at 51 time points over 3.6 years provided a time series of gut microbial species' relative abundances, from which we generated time-point specific microbiome models. Flux balance analysis was used to predict metabolic phenotypes across the time series. The microbial abundances and predicted fluxes were compared with clinical inflammation biomarkers [serum C-reactive protein (CRP); stool lactoferrin, calprotectin, lysozyme, and secretory immunoglobulin A]. Each of these 51 microbiome models were integrated with a time-point specific male whole-body metabolic model personalized based on LS's weight, blood glucose, and cholesterol. A healthy average (HeAve) community model from 34 individuals provided a reference. Our models predicted methane overproduction from high Methanobrevibacter smithii levels, coinciding with peak CRP and calprotectin. We found that Escherichia coli plays a central role in shaping the predicted metabolome and may promote inflammation through trimethylamine N-oxide and formaldehyde production, out-competing Desulfovibrio piger and Akkermansia muciniphila via active methyl and sulfur cycles. At a later time point, LS experienced a major shift in gut Proteobacteria ecology: E. coli, over-abundant at 675 × HeAve, dropped nearly 80-fold in one month, while Morganella morganii rose by nearly eight times, which coincided with a spike in LS's lactoferrin and lysozyme, a rise in species including Klebsiella pneumoniae and Faecalibacterium prausnitzii, a change in predicted metabolic profile, and increased alpha diversity. We also noted a correlation between postulated inflammation periods and predicted lithocholic acid levels. This work extends two previous studies of 7 and 27 of these time points. Our analysis demonstrates the value of pairing multi-omics time-series data with systems biology approaches in an n-of-1 design, resolving how microbiome composition dynamics shape host–microbiome metabolism and inflammation.
No takes yet. Share an insight, caveat, or question.
Sheehy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: